Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
FEBS Letters|August 4, 1998
Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domainA J Fosang, K Last, Y Fujii, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 2, 2008
Keratan sulphate in the interglobular domain has a microstructure that is distinct from keratan sulphate elsewhere on pig aggrecanA J Fosang, K Last, C J Poon, et al.
Clinical and Experimental Immunology|November 1, 1982
Recovery of humoral and cellular immunity by soluble mediators after 5-fluorouracil-induced immunosuppressionV J Merluzzi, K Last-Barney, B M Susskind, et al.
FEBS Letters|February 12, 1996
Degradation of cartilage aggrecan by collagenase-3 (MMP-13)A J Fosang, K Last, V Knäuper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1988
Synergistic and overlapping activities of tumor necrosis factor-alpha and IL-1K Last-Barney, C A Homon, R B Faanes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2V J Merluzzi, K Welte, D M Savage, et al.
Biochemical and Biophysical Research Communications|January 15, 1991
Recombinant human interleukin-1 inhibits plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytesI K Campbell, K Last, U Novak, et al.
IARC Scientific Publications|January 1, 1980
N6-(Methylnitroso)adenosine: a carcinogen from a nucleic acid componentA Giner-Sorolla, L M Anderson, J H Greenbaum, et al.
Pageof 5